Offshore
Photo
Dimitry Nakhla | Babylon Capital®
Interesting to compare FCF Estimates of $AMZN $NVDA $GOOG & $MSFT 💵
• By the end of 2028, $AMZN is projected to generate more FCF ($142.34B) than the rest 💸
• $NVDA is projected to nearly triple its FCF in 2 years (2024-2026) 🤯
• Despite $NVDA outstanding growth, $GOOG & $MSFT FCF projections are still impressive 📈
Current valuations:
• $AMZN 1.96T
• $NVDA 3.00T
• $GOOG 2.25T
• $MSFT 3.34T
Any thoughts? Comment below 👇🏽
#stocks #investing
tweet
Interesting to compare FCF Estimates of $AMZN $NVDA $GOOG & $MSFT 💵
• By the end of 2028, $AMZN is projected to generate more FCF ($142.34B) than the rest 💸
• $NVDA is projected to nearly triple its FCF in 2 years (2024-2026) 🤯
• Despite $NVDA outstanding growth, $GOOG & $MSFT FCF projections are still impressive 📈
Current valuations:
• $AMZN 1.96T
• $NVDA 3.00T
• $GOOG 2.25T
• $MSFT 3.34T
Any thoughts? Comment below 👇🏽
#stocks #investing
tweet
Dimitry Nakhla | Babylon Capital®
RT @DimitryNakhla: Looking back at some of your best investment decisions & your worst investment mistakes can help you become a better investor 💸
Mistake # 1 & Best # 3 are my favorites ‼️
You will benefit from reading this, these are things I wish I knew early on 💯
Here are 3 of my biggest MISTAKES 👎🏽:
1️⃣ I waited too long to buy high-quality businesses — I was mentored in 2016 & my mentor was a VALUE first investor (rather than QUALITY first) & was heavily influenced by Benjamin Graham’s ideologies as it related to low multiples, tangible assets, etc.
Higher multiples scared him off and as a result, scared me off as well
I did not understand why some companies deserved to trade at a premium & would continue to demand a premium
The opportunity cost here included owning companies like $V $MA $COST $GOOG $SHW all the way back in 2016 — companies I was interested in buying & owning but ended up never buying due to their multiples
2️⃣ Selling $ABBV after a 100% gain
When the Brexit crisis happened in June 2016 I accumulated shares of $ABBV near $58. When $ABBV acquired Allergan for a P/B <1 i accumulated even more shares near $57
i liquidated my $abbv holding for a ~100% gain at $120 — a big mistake, here’s why:
today, $abbv dividend is $6.20 per share meaning that my yield on cost would have been ~10.5% 🤯
imagine getting 10.5% of your original investment from dividends (along with future dividend growth)
while biotech & biopharma can be volatile, i under-appreciated $abbv pipeline, corporate culture stemming from $abt (a dividend aristocrat), quality & total return potential. i should have been more patient and considered it an untouchable holding unless, of course, the fundamentals began to crack
3️⃣ early in my investing journey, i used to find comfort (a false comfort) in knowing i was invested in the same companies as some investors that i looked up to — this is a mistake because if you don’t build your own conviction (through research & a well defined system), you will likely lack the courage to hold through bad times or to even add more during bad times
_______
here are 3 of my best decisions 👍🏽:
1️⃣ i cannot emphasize how important it is to have an insatiable curiosity as an investor … read, read, read … reading @chriswmayer 100 baggers led me to find $cprt & appreciate the quality (especially linearity) of the business. just that one find made reading the book worth it 10x over
reading nick sleep’s investor letters led me to appreciate why scale economics is such an important concept to understand, $cost & $amzn are two great examples (core holdings of the nomad investment partnership) of catching quality businesses early on that benefit from scale economics — it’s like a snowball that continues to get bigger as it rolls down a mountain
seth klarman’s margin of safety, berkshire’s investment letters, market wizards, etc.
always read & learn, it will make you a better investor
2️⃣ contrary to mistake 1, one of the best investment decisions was understanding why some companies maintain premium multiples & adding them at opportune times despite the fact that they may have seemed “expensive”
it also helps to analyze the valuations of these businesses relative to growth (think peg)
e.g. $cprt $asml $v $ma $odfl $acn $fast are all core holdings in my portfolio now & businesses i plan to own long-term
3️⃣ simplifying your process — whether you’re an investor or trader, it really helps to simplify complex topics
while some may think complexity makes them look smarter, simplification is actually more difficult because it requires you to really understand what matters & if it’s simple — it’s easier to replicate, bringing more consistency in your results
think the pareto principle, 80% of the consequences come from 20% of causes
my investment process comes down to analyzing quality (balance sheet, returns on capital, consistency in fcf & eps growth) & then valuation relative to growth 💯
#stocks #investing
tweet
RT @DimitryNakhla: Looking back at some of your best investment decisions & your worst investment mistakes can help you become a better investor 💸
Mistake # 1 & Best # 3 are my favorites ‼️
You will benefit from reading this, these are things I wish I knew early on 💯
Here are 3 of my biggest MISTAKES 👎🏽:
1️⃣ I waited too long to buy high-quality businesses — I was mentored in 2016 & my mentor was a VALUE first investor (rather than QUALITY first) & was heavily influenced by Benjamin Graham’s ideologies as it related to low multiples, tangible assets, etc.
Higher multiples scared him off and as a result, scared me off as well
I did not understand why some companies deserved to trade at a premium & would continue to demand a premium
The opportunity cost here included owning companies like $V $MA $COST $GOOG $SHW all the way back in 2016 — companies I was interested in buying & owning but ended up never buying due to their multiples
2️⃣ Selling $ABBV after a 100% gain
When the Brexit crisis happened in June 2016 I accumulated shares of $ABBV near $58. When $ABBV acquired Allergan for a P/B <1 i accumulated even more shares near $57
i liquidated my $abbv holding for a ~100% gain at $120 — a big mistake, here’s why:
today, $abbv dividend is $6.20 per share meaning that my yield on cost would have been ~10.5% 🤯
imagine getting 10.5% of your original investment from dividends (along with future dividend growth)
while biotech & biopharma can be volatile, i under-appreciated $abbv pipeline, corporate culture stemming from $abt (a dividend aristocrat), quality & total return potential. i should have been more patient and considered it an untouchable holding unless, of course, the fundamentals began to crack
3️⃣ early in my investing journey, i used to find comfort (a false comfort) in knowing i was invested in the same companies as some investors that i looked up to — this is a mistake because if you don’t build your own conviction (through research & a well defined system), you will likely lack the courage to hold through bad times or to even add more during bad times
_______
here are 3 of my best decisions 👍🏽:
1️⃣ i cannot emphasize how important it is to have an insatiable curiosity as an investor … read, read, read … reading @chriswmayer 100 baggers led me to find $cprt & appreciate the quality (especially linearity) of the business. just that one find made reading the book worth it 10x over
reading nick sleep’s investor letters led me to appreciate why scale economics is such an important concept to understand, $cost & $amzn are two great examples (core holdings of the nomad investment partnership) of catching quality businesses early on that benefit from scale economics — it’s like a snowball that continues to get bigger as it rolls down a mountain
seth klarman’s margin of safety, berkshire’s investment letters, market wizards, etc.
always read & learn, it will make you a better investor
2️⃣ contrary to mistake 1, one of the best investment decisions was understanding why some companies maintain premium multiples & adding them at opportune times despite the fact that they may have seemed “expensive”
it also helps to analyze the valuations of these businesses relative to growth (think peg)
e.g. $cprt $asml $v $ma $odfl $acn $fast are all core holdings in my portfolio now & businesses i plan to own long-term
3️⃣ simplifying your process — whether you’re an investor or trader, it really helps to simplify complex topics
while some may think complexity makes them look smarter, simplification is actually more difficult because it requires you to really understand what matters & if it’s simple — it’s easier to replicate, bringing more consistency in your results
think the pareto principle, 80% of the consequences come from 20% of causes
my investment process comes down to analyzing quality (balance sheet, returns on capital, consistency in fcf & eps growth) & then valuation relative to growth 💯
#stocks #investing
tweet
Offshore
Photo
AkhenOsiris
RT @ConsensusGurus: Micron $MU Earnings Setup - Stock Sits at an ATH and Expensive P/E
Data in the table is choppy due to EPS dipping into negative territory recently, but 19x off of $7/sh expected earnings reflects expectations for a new spending cycle in the memory sector.
Results tomorrow AH.
tweet
RT @ConsensusGurus: Micron $MU Earnings Setup - Stock Sits at an ATH and Expensive P/E
Data in the table is choppy due to EPS dipping into negative territory recently, but 19x off of $7/sh expected earnings reflects expectations for a new spending cycle in the memory sector.
Results tomorrow AH.
Earnings Setup Heatmap for the Week Ahead
Another light week, but some very big, important names. Will $NKE swap out their c-suite?
$NKE $WS $GIS $PAYX $FDX $CNXC $MLKN $SMPL $ANCTF $CRML $WBA $JEF $FIZZ $EPAC $CCL $MDRX $MKC $UNF $PRGS $FUL $GBX $SPWR $SNX $MU $LEVI $MANU $LNN $LZM $BB $AYI $WOR $APOG $AVAV $DAKT - CGtweet
AkhenOsiris
$NVDA
Cantor Fitzgerald analyst C.J. Muse raises target to $175 (from $140), maintains Overweight rating.
"As NVDA has now grown to be one of the largest market cap companies globally (~$3T), the clear question is, how much more room does the stock have to run? In our view, quite a bit. We have never seen a more-torrid pace of technology innovation and subsequent reduction in cost of compute as we are seeing today - all driven by NVDA and its full system approach. These dynamics are causing a strategic inflection in the proliferation of AI today, with no signs of slowing anytime soon given accelerating product cycles (NVDA now on annual cadence), continued software innovation, and optimizations across the stack allowing for a significant scale out of the compute unit. With this rapid pace of innovation, NVDA is only strengthening its already-robust moat, forcing competitors into playing an ongoing game of catch-up. Based on the above and NVIDIA's clear technologic push at scale, we continue to look for the shares to push higher. We reiterate our Overweight rating, the shares remain a TOP PICK, and we are raising our price target to $175 from $140."
tweet
$NVDA
Cantor Fitzgerald analyst C.J. Muse raises target to $175 (from $140), maintains Overweight rating.
"As NVDA has now grown to be one of the largest market cap companies globally (~$3T), the clear question is, how much more room does the stock have to run? In our view, quite a bit. We have never seen a more-torrid pace of technology innovation and subsequent reduction in cost of compute as we are seeing today - all driven by NVDA and its full system approach. These dynamics are causing a strategic inflection in the proliferation of AI today, with no signs of slowing anytime soon given accelerating product cycles (NVDA now on annual cadence), continued software innovation, and optimizations across the stack allowing for a significant scale out of the compute unit. With this rapid pace of innovation, NVDA is only strengthening its already-robust moat, forcing competitors into playing an ongoing game of catch-up. Based on the above and NVIDIA's clear technologic push at scale, we continue to look for the shares to push higher. We reiterate our Overweight rating, the shares remain a TOP PICK, and we are raising our price target to $175 from $140."
tweet
Offshore
Video
AkhenOsiris
A.I. is taking jobs of legends like Al Michaels. 😱
tweet
A.I. is taking jobs of legends like Al Michaels. 😱
NBC has announced that it will use A.I. to recreate Al Michaels’ voice for custom recaps during the 2024 Olympics. - Front Office Sportstweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
RT @DimitryNakhla: 2 Facts About $NVDA That May Surprise You 🤯
1️⃣ Despite rallying 536.25% in the last 3 years, $NVDA multiple compressed (NTM) from 44.06x to 37.55x (-14.76% compression)
In other words, $NVDA appears to be cheaper today than it was 3 years ago
___
2️⃣ $NVDA has demonstrated remarkable earnings growth, with EPS compounding at an impressive 73.06% annual rate from 2021 to 2024. Looking ahead, analysts expect this momentum to continue, with EPS projected to compound at an even more robust 78.53% annual rate from 2021 to 2025E
$NVDA shocking increase in price has been well supported by the fundamentals
_______
#stocks #investing
tweet
RT @DimitryNakhla: 2 Facts About $NVDA That May Surprise You 🤯
1️⃣ Despite rallying 536.25% in the last 3 years, $NVDA multiple compressed (NTM) from 44.06x to 37.55x (-14.76% compression)
In other words, $NVDA appears to be cheaper today than it was 3 years ago
___
2️⃣ $NVDA has demonstrated remarkable earnings growth, with EPS compounding at an impressive 73.06% annual rate from 2021 to 2024. Looking ahead, analysts expect this momentum to continue, with EPS projected to compound at an even more robust 78.53% annual rate from 2021 to 2025E
$NVDA shocking increase in price has been well supported by the fundamentals
_______
#stocks #investing
tweet
Dimitry Nakhla | Babylon Capital®
“The individual investor should act consistently as an investor and not as a speculator.
He should be able to justify every purchase he makes and each price he pays by impersonal, objective reasoning that satisfies him that he is getting more than his money's worth for the purchase.”
— Benjamin Graham 🗣️
#stocks #investing
tweet
“The individual investor should act consistently as an investor and not as a speculator.
He should be able to justify every purchase he makes and each price he pays by impersonal, objective reasoning that satisfies him that he is getting more than his money's worth for the purchase.”
— Benjamin Graham 🗣️
#stocks #investing
tweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
And I still believe market participants are underestimating $AMZN FCF growth potential 👇🏽
#stocks #investing https://t.co/oPSI0YN0RD
tweet
And I still believe market participants are underestimating $AMZN FCF growth potential 👇🏽
#stocks #investing https://t.co/oPSI0YN0RD
Interesting to compare FCF Estimates of $AMZN $NVDA $GOOG & $MSFT 💵
• By the end of 2028, $AMZN is projected to generate more FCF ($142.34B) than the rest 💸
• $NVDA is projected to nearly triple its FCF in 2 years (2024-2026) 🤯
• Despite $NVDA outstanding growth, $GOOG & $MSFT FCF projections are still impressive 📈
Current valuations:
• $AMZN 1.96T
• $NVDA 3.00T
• $GOOG 2.25T
• $MSFT 3.34T
Any thoughts? Comment below 👇🏽
#stocks #investing tweet